Differential expression of CDO1 in cancers of the breast.

Shahan Mamoor

DOI: https://doi.org/10.31219/osf.io/5x2bc

2021-05-03

Abstract:Breast cancer affects women at relatively high frequency (1). We mined published microarray datasets (2, 3) to determine in an unbiased fashion and at the systems level genes most differentially expressed in the primary tumors of patients with breast cancer. We report here significant differential expression of the gene encoding cysteine dioxygenase, type I, CDO1, when comparing primary tumors of the breast to the tissue of origin, the normal breast. CDO1 was also differentially expressed in the tumor cells of patients with triple negative breast cancer. CDO1 mRNA was present at significantly lower quantities in tumors of the breast as compared to normal breast tissue. Analysis of human survival data revealed that expression of CDO1 in primary tumors of the breast was correlated with overall survival in patients with luminal B subtype cancer, demonstrating a relationship between primary tumor expression of a differentially expressed gene and patient survival outcomes influenced by molecular subtype. CDO1 may be of relevance to initiation, maintenance or progression of cancers of the female breast.